Bayer AG Sponsored ADR logo

Bayer AG Sponsored ADR (BAYA)

Market Closed
17 Jul, 20:00
XMUN XMUN
12. 10
0
0%
18.55B Market Cap
- P/E Ratio
10.54% Div Yield
205 Volume
0 Eps
12.1
Previous Close
Add Transaction
Day Range
12.1 12.1
Year Range
6.35 13.5
Want to track BAYA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BAYA closed yesterday higher at €12.1, an increase of 0% from Thursday's close, completing a monthly increase of 30.1075% or €2.8. Over the past 12 months, BAYA stock gained 32.967%.
BAYA pays dividends to its shareholders, with the most recent payment made on May 11, 2026. The next estimated payment will be in In 9 months on May 11, 2027 for a total of €0.0321.
The last earnings report, released on May 12, 2026, missed the consensus estimates by -0.6373%. On average, the company has fell short of earnings expectations by -0.2251%, based on the last three reports.
Bayer AG Sponsored ADR has completed 1 stock splits, with the recent split occurring on Sep 20, 2017.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

BAYA Chart

Bayer: Debt Remains A Problem, Value Remains Compelling

Bayer: Debt Remains A Problem, Value Remains Compelling

Bayer Aktiengesellschaft remains undervalued despite a strong 18-month rally and ongoing operational improvements. I see upside potential supported by improving EBIT, robust pipeline assets, and technical breakout, though litigation and high debt persist. Litigation settlements and negative free cash flow weigh on the balance sheet, but recent Apollo investment and restructuring efforts provide some relief.

Seekingalpha | 6 days ago
Apollo to Buy $3.4 Billion Stake in Bayer Contraceptives Business

Apollo to Buy $3.4 Billion Stake in Bayer Contraceptives Business

The asset-management firm agreed to buy a minority stake in Bayer's long-acting reversible contraceptives business.

Wsj | 1 week ago
BAYRY Stock Surges 17% After Supreme Court Roundup Ruling

BAYRY Stock Surges 17% After Supreme Court Roundup Ruling

Bayer shares jump 17% after a Supreme Court ruling on Roundup litigation that could significantly reduce warning-based claims and litigation costs.

Zacks | 3 weeks ago

Bayer AG Sponsored ADR (BAYA) FAQ

What is the stock price today?

The current price is €12.10.

On which exchange is it traded?

Bayer AG Sponsored ADR is listed on XMUN.

What is its stock symbol?

The ticker symbol is BAYA.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 10.54%.

What is its market cap?

As of today, the market cap is 18.55B.

Has Bayer AG Sponsored ADR ever had a stock split?

Bayer AG Sponsored ADR had 1 splits and the recent split was on Sep 20, 2017.

Bayer AG Sponsored ADR Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
William N. Anderson CEO
XMUN Exchange
US0727303028 ISIN
DE Country
90,587 Employees
28 Apr 2026 Last Dividend
20 Sep 2017 Last Split
- IPO Date

Overview

Bayer Aktiengesellschaft is a globally recognized life science company that operates worldwide with a vast array of subsidiaries. Established in 1863 and with its headquarters located in Leverkusen, Germany, the company engages in extensive research, development, and marketing activities across three major segments: Pharmaceuticals, Consumer Health, and Crop Science. Bayer's mission is to address some of the most pressing global challenges by providing innovative solutions in healthcare and agriculture. The company has fostered numerous collaborations with leading entities such as Acuitas Therapeutics, Inc., Peking University, the Swiss Tropical and Public Health Institute, bit.bio Ltd., Hologic, Inc., Twist Bioscience Corporation, and CrossBay Medical Inc., among others. These partnerships mainly focus on advancing Bayer's research initiatives in gene editing, pharmaceutical research, the development of therapeutics, and improving diagnostic solutions for diseases like breast cancer. Additionally, Bayer teams up with Thermo Fisher Scientific, further enhancing its product distribution capabilities which span wholesalers, pharmacies, supermarket chains, online retailers, hospitals, and direct sales to farmers.

Products and Services

  • Pharmaceuticals Segment

    This division primarily focuses on the development and sale of prescription medications in cardiology and women’s health care. It also encompasses specialty therapeutics in oncology, hematology, ophthalmology, and the burgeoning fields of cell and gene therapy. Moreover, Bayer is involved in the provision of diagnostic imaging equipment and solutions, along with contrast agents, catering to the healthcare industry's needs for precise and early disease detection.

  • Consumer Health Segment

    Under this segment, Bayer markets a wide array of non-prescription, over-the-counter medicines designed for self-medication and self-care. The products span various categories including nutritional supplements, allergy relief, cough and cold remedies, dermatology, pain management, cardiovascular risk prevention, and digestive health. This segment illustrates Bayer's commitment to supporting everyday health and wellness through accessible healthcare solutions.

  • Crop Science Segment

    This sector of Bayer’s operations is dedicated to the agricultural industry, focusing on the breeding, propagation, and production/processing of seeds. Offerings also include seed dressing technologies aimed at improving crop yields and resilience. By integrating scientific advancements into agriculture, Bayer seeks to address food security and sustainability challenges, reinforcing its role in supporting the agricultural community.

Contact Information

Address: Kaiser-Wilhelm-Allee 1
Phone: 49 214 30 1